lenalidomide has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larsen, LH; Lund, T; Plesner, T; Vilholm, OJ | 1 |
| Kuwabara, S | 1 |
1 review(s) available for lenalidomide and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
[New treatment strategy for Crow-Fukase (POEMS) syndrome].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Combined Modality Therapy; Demyelinating Diseases; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2010 |
1 other study(ies) available for lenalidomide and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Anti-myelin associated glycoprotein neuropathy responding to lenalidomide.
Topics: Aged; Antineoplastic Agents; Demyelinating Diseases; Humans; Immunoglobulin M; Lenalidomide; Male; Myelin-Associated Glycoprotein; Paraproteinemias; Peripheral Nervous System Diseases; Thalidomide | 2011 |